- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
AptarGroup Inc (ATR)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: ATR (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $161.43
1 Year Target Price $161.43
| 4 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -9.98% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.00B USD | Price to earnings Ratio 19.5 | 1Y Target Price 161.43 |
Price to earnings Ratio 19.5 | 1Y Target Price 161.43 | ||
Volume (30-day avg) 7 | Beta 0.5 | 52 Weeks Range 103.23 - 164.86 | Updated Date 12/14/2025 |
52 Weeks Range 103.23 - 164.86 | Updated Date 12/14/2025 | ||
Dividends yield (FY) 1.53% | Basic EPS (TTM) 6.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.45% | Operating Margin (TTM) 15.15% |
Management Effectiveness
Return on Assets (TTM) 6.84% | Return on Equity (TTM) 15.62% |
Valuation
Trailing PE 19.5 | Forward PE 24.1 | Enterprise Value 8955745636 | Price to Sales(TTM) 2.19 |
Enterprise Value 8955745636 | Price to Sales(TTM) 2.19 | ||
Enterprise Value to Revenue 2.45 | Enterprise Value to EBITDA 10.65 | Shares Outstanding 65619154 | Shares Floating 65073859 |
Shares Outstanding 65619154 | Shares Floating 65073859 | ||
Percent Insiders 1.07 | Percent Institutions 96.02 |
About AptarGroup Inc
Exchange NYSE | Headquaters Crystal Lake, IL, United States | ||
IPO Launch date 1993-04-21 | President, CEO & Executive Director Mr. Stephan B. Tanda | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 13500 | Website https://www.aptar.com |
Full time employees 13500 | Website https://www.aptar.com | ||
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

